UY34339A - Inhibidores de la fosfatidilinositol 3-quinasa para el tratamiento del cancer - Google Patents
Inhibidores de la fosfatidilinositol 3-quinasa para el tratamiento del cancerInfo
- Publication number
- UY34339A UY34339A UY0001034339A UY34339A UY34339A UY 34339 A UY34339 A UY 34339A UY 0001034339 A UY0001034339 A UY 0001034339A UY 34339 A UY34339 A UY 34339A UY 34339 A UY34339 A UY 34339A
- Authority
- UY
- Uruguay
- Prior art keywords
- quinase
- phosphytidylinositol
- inhibitors
- cancer treatment
- página
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 241000950314 Figura Species 0.000 abstract 2
- FWYUJENICVGSJH-UHFFFAOYSA-M sodium;2-[bis[2-[2-(2-methyl-5-nitroimidazol-1-yl)ethoxy]-2-oxoethyl]amino]acetate Chemical compound [Na+].CC1=NC=C([N+]([O-])=O)N1CCOC(=O)CN(CC([O-])=O)CC(=O)OCCN1C([N+]([O-])=O)=CN=C1C FWYUJENICVGSJH-UHFFFAOYSA-M 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161534836P | 2011-09-14 | 2011-09-14 | |
| US201161543529P | 2011-10-05 | 2011-10-05 | |
| US201161562670P | 2011-11-22 | 2011-11-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY34339A true UY34339A (es) | 2013-04-30 |
Family
ID=46940622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001034339A UY34339A (es) | 2011-09-14 | 2012-09-14 | Inhibidores de la fosfatidilinositol 3-quinasa para el tratamiento del cancer |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP2755654A1 (enExample) |
| KR (1) | KR20140077911A (enExample) |
| AU (1) | AU2012308414A1 (enExample) |
| BR (1) | BR112014005858A2 (enExample) |
| CA (1) | CA2848724A1 (enExample) |
| IL (1) | IL231448A0 (enExample) |
| IN (1) | IN2014CN02671A (enExample) |
| TW (1) | TW201325592A (enExample) |
| UY (1) | UY34339A (enExample) |
| WO (1) | WO2013040337A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113754565B (zh) * | 2021-11-09 | 2022-02-22 | 南京威凯尔生物医药科技有限公司 | 一种连续流微反应器中制备沙库巴曲中间体的方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4107288A (en) | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| US7019002B2 (en) | 2001-12-11 | 2006-03-28 | Pharmacia & Upjohn, S.P.A. | Pyridopyrimidinones derivatives as telomerase inhibitors |
| WO2007044729A2 (en) * | 2005-10-07 | 2007-04-19 | Exelixis, Inc. | N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors |
| EP1940839B1 (en) | 2005-10-07 | 2013-07-31 | Exelixis, Inc. | PYRIDOPYRIMIDINONE INHIBITORS OF PI3Kalpha |
| WO2007044481A1 (en) | 2005-10-07 | 2007-04-19 | Basf Corporation | Clearcoat coating composition |
| RS53020B (sr) * | 2007-04-11 | 2014-04-30 | Exelixis Inc. | Kombinovane terapije koje sadrže hinoksalin inhibitor pi3k-alfa za upotrebu u lečenju kancera |
| WO2010146391A1 (en) * | 2009-06-15 | 2010-12-23 | Generics [Uk] Limited | Regioselective synthesis of letrozole |
| WO2012065057A2 (en) * | 2010-11-12 | 2012-05-18 | Exelixis, Inc. | Phosphatidylinositol 3-kinase inhibitors and methods of their use |
-
2012
- 2012-09-14 IN IN2671CHN2014 patent/IN2014CN02671A/en unknown
- 2012-09-14 TW TW101133789A patent/TW201325592A/zh unknown
- 2012-09-14 BR BR112014005858A patent/BR112014005858A2/pt not_active Application Discontinuation
- 2012-09-14 KR KR1020147009539A patent/KR20140077911A/ko not_active Withdrawn
- 2012-09-14 AU AU2012308414A patent/AU2012308414A1/en not_active Abandoned
- 2012-09-14 CA CA2848724A patent/CA2848724A1/en not_active Abandoned
- 2012-09-14 UY UY0001034339A patent/UY34339A/es not_active Application Discontinuation
- 2012-09-14 EP EP12766542.0A patent/EP2755654A1/en not_active Withdrawn
- 2012-09-14 WO PCT/US2012/055387 patent/WO2013040337A1/en not_active Ceased
-
2014
- 2014-03-11 IL IL231448A patent/IL231448A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IN2014CN02671A (enExample) | 2015-07-03 |
| WO2013040337A1 (en) | 2013-03-21 |
| TW201325592A (zh) | 2013-07-01 |
| IL231448A0 (en) | 2014-04-30 |
| WO2013040337A9 (en) | 2014-04-03 |
| CA2848724A1 (en) | 2013-03-21 |
| BR112014005858A2 (pt) | 2017-06-13 |
| EP2755654A1 (en) | 2014-07-23 |
| KR20140077911A (ko) | 2014-06-24 |
| AU2012308414A1 (en) | 2014-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY33925A (es) | Inhibidores tricíclicos de quinasas | |
| UY34550A (es) | Bencilpirazoles sustituidos | |
| UY34648A (es) | Amidas como inhibidores de pim | |
| UY34145A (es) | Compuestos inhibidores de metaloenzimas | |
| UY34146A (es) | Compuestos inhibidores de metaloenzimas | |
| UY34374A (es) | Benzilindazoles sustituidos | |
| UY34201A (es) | Compuestos de azaindol y métodos para el tratamiento de vih. | |
| UY4149Q (es) | Golosina para mascota | |
| UY34045A (es) | Derivados de imidazopiridina como inhibidores de pi3k | |
| UY34156A (es) | Compuestos inhibidores de metaloenzimas | |
| UY34472A (es) | Derivados modificados de 4-fenil-piridina | |
| UY34657A (es) | ?derivados macrocíclicos para el tratamiento de enfermedades?. | |
| UY34051A (es) | Derivados de pirrolotriazinona como inhibidores de pi3k | |
| UY34523A (es) | Derivados de betulina | |
| UY34541A (es) | ?derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina?. | |
| UY34039A (es) | Compuestos fungicidas | |
| GT201400133A (es) | Inhibidores de bromodominios | |
| UY34034A (es) | Triazolopiridinas | |
| UY34092A (es) | Nuevos compuestos como inhibidores de jak | |
| UY34037A (es) | Nuevo compuesto útil para el tratamiento de enfermedades degenerativas e inflamatorias. | |
| UY33929A (es) | Compuestos de ciclohexilo tetrasustituido como inhibidores de quinasas | |
| UY33627A (es) | Compuestos para tratar enfermedades neurodegenerativas | |
| UY34545A (es) | Novedosas dihidropirimidinoisoquinolinonas y composiciones farmacéuticas de las mismas para el tratamiento de trastornos inflamatorios. | |
| EA201400178A1 (ru) | Лечение рака молочной железы | |
| UY33910A (es) | 6-cicloalquil-pirazolopirimidinonas para el tratamiento de trastornos del SNC |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20201020 |